Immuno-Oncology and the Gut Microbiome - Enduring

The field of research regarding the gut microbiome and immuno-oncology is still relatively new and burgeoning. To date, there have been few large-scale prospective trials in this field and many studies are exploratory. Over the past few years, much attention has been focused on the gut microbiome and its impact on immuno-based cancer therapeutics. Although there exists evidence suggesting that modulating the gut microbiome may impact responses to immunotherapy, optimal strategies of how to achieve this are unclear and examined in an exploratory fashion. 

Target Audience

Physicians, nurses, and all other health care providers interested in the topic.

Learning Objectives

  • Demonstrate an understanding of the evidence and mechanisms behind the gut microbiome's potential to modulate cancer patients' responses to immunotherapy.
  • Discuss results of human studies to-date that have shown a critical role of the gut microbiome in impacting survival and tumor responses to immunotherapy. 
  • Outline ongoing trials of the gut microbiome and immuno-oncology at City of Hope.
  • Integrate gut microbiome studies in future projects.
     

Additional Information

AttachmentSize
AB 1195 Bibliography243.1 KB
Activity summary
Available credit: 
  • 1.00 AMA PRA Category 1 Credit™
    City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    City of Hope designates this Immuno-Oncology and the Gut Microbiome - Enduring for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
Activity opens: 
08/27/2020
Activity expires: 
08/27/2021
Internet
United States

This activity has been planned and implemented in strict compliance with the accreditation requirements, standards, and policies of the ACCME. City of Hope takes responsibility for the content, quality and scientific integrity of this CME activity.

As an accredited CME provider City of Hope requires everyone who is in a position to control the content of an educational activity to disclose all relevant financial relationships with any commercial interest. The ACCME defines "relevant financial relationships" as financial relationships in any amount, occurring within the past 12 months, including financial relationships of a spouse that could create a conflict of interest. Any potential conflicts relative to the previous disclosure have been resolved.

Presenter: Dr. Sarah K. Highlander has indicated that there is nothing to disclose.

City of Hope further encourages faculty/ authors to identify investigational products or off-label uses of products regulated by the U.S. Food and Drug Administration, at first mention and where appropriate in the content.

This activity will include a discussion of the off-label or investigational use of Paricalcitol.

The information and opinions presented in this activity do not constitute medical or legal advice. Health care providers must exercise their own professional judgment in their clinical practice, and when confronted with the issues discussed herein, should not substitute this curriculum for the advice of legal counsel or application of sound ethical principles.

Immuno-Oncology and the Gut Microbiome has received no commercial support.

ACCREDITATION STATEMENT: City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

CREDIT DESIGNATION: City of Hope designates this enduring activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

The following credit type(s) are being offered for this course:

 
•  AMA PRA Category 1™  1.0

The following may apply AMA PRA Category 1 Credit™ for license renewal:

Registered Nurses: Nurses may report up to 1.0 credit hours toward the continuing education requirements for license renewal by their state Board of Registered Nurses (BRN). AMA PRA Category 1 Credit™ may be noted on the license renewal application in lieu of a BRN provider number.

Physician Assistants: The National Commission on Certification of Physicians Assistants states that AMA PRA Category 1 Credit™ accredited courses are acceptable for CME requirements for recertification.

Available Credit

  • 1.00 AMA PRA Category 1 Credit™
    City of Hope is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
    City of Hope designates this Immuno-Oncology and the Gut Microbiome - Enduring for a maximum of 1.00 AMA PRA Category 1 Credit™ requirements. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.00 Attendance
Please login or register to take this activity.

Once logged in, please click on "Start Activity" to take this Enduring.

Required Hardware/software

Current version of Edge, Firefox, Safari, or Chrome.